Cronos Group Further Delays Filings, Reduces Prior Revenue Figures By $7.6 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) announced this evening that further to it’s previous release, the company will be delaying the release of its fiscal 2019 financial results yet again, this time until March 30, 2020. Additionally, the company has indicated that previously released financials should no longer be relied upon.

Cronos Group identified that in connection with the previously released financials for the first, second, and third quarters of 2019 that the company will also be reducing previously released revenue figures as a result of several bulk resin purchases and wholesaling agreements. The purchases, which The Deep Dive has covered at length, have the net effect of reducing Cronos first quarter revenues by $2.5 million, bringing gross revenues to an estimated $4.4 million for the quarter.

Third quarter results have also been impacted to the tune of $5.1 million, reducing the firms third quarter results from a gross figure of $13.3 million to that of an estimated $8.2 million. Collectively, the firms 2019 revenue figures are expected to decline by at least $7.6 million based on preliminary data released by Cronos Group.

Cronos Group now expects to release its fiscal 2019 results by March 30, however the company again provided no guarantee on this occurring.

Cronos Group last traded at $5.96 on the Nasdaq.


Information for this analysis was found via Sedar and Cronos Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Isn’t In A Bubble, Currency Is. – Doug Casey

The Real Move Begins When They Cut Rates | Peter Krauth

Is Altamira Gold Sitting On Brazil’s Next Big Gold Discovery?

Recommended

Stifel Initiates Coverage On Goliath Resources With $5.00 Price Target

ESGold Completes Mill Building Construction, Final Equipment Procurement Underway

Related News

Canadian Cannabis: Canaccord Lifts Cronos Target, Reiterates Canopy Growth And Tilray Ratings

Yesterday Canaccord Genuity Capital Markets put out a second-quarter preview note on the top Canadian...

Thursday, July 28, 2022, 03:02:00 PM

Cronos Group Posts Revenues of US$7.3 Million For Q4 2019, Loss of US$63.8 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) has finally reported its fourth quarter and full fiscal...

Monday, March 30, 2020, 04:36:32 PM

PI Financial, Canaccord Revise Cronos Group Estimates Downward Following Q3 Results

Last week, Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its third quarter 2020 results. The...

Sunday, November 8, 2020, 11:39:00 AM

Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement

Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their...

Thursday, September 19, 2019, 09:23:17 AM

SEC Charges Cronos Group With Accounting Fraud

Canadian cannabis company Cronos Group Inc (TSX: CRON) and its former senior executive were charged...

Monday, October 24, 2022, 05:52:17 PM